Prostate squamous cell carcinoma developing 11 years after external radiotherapy for prostate adenocarcinoma

Prostate squamous cell carcinoma developing 11 years after external radiotherapy for prostate adenocarcinoma

Introduction Secondary bladder, colon, and rectal cancers are relatively common after prostate radiotherapy. However, secondary squamous cell carcinoma of the prostate is rare. Case presentation An 85‐year‐old man presented with dysuria and low‐serum prostate‐specific antigen levels. His medical his...

Full description

Bibliographic Details
Main Authors:	Toru Matsugasumi, Hiroyuki Nakanishi, Tomohiro Yokota, Takumi Shiraishi, Osamu Ukimura
Format:	Article
Language:	English
Published:	Wiley 2020-07-01
Series:	IJU Case Reports
Subjects:	prostate‐specific antigen radiotherapy secondary prostate cancer squamous cell carcinoma
Online Access:	https://doi.org/10.1002/iju5.12161

Similar Items

Biochemical failure as single abnormality in patients with prostate cancer following radical treatment with external radiotherapy: follow-up without immediate treatment
by: Sergio L. Faria, et al.
Published: (2004-08-01)

Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer
by: Hun Jung Kim, et al.
Published: (2015-12-01)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
by: Yadong Guo, et al.
Published: (2019-07-01)

Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer
by: Narisa Dewi Maulany Darwis, et al.
Published: (2020-03-01)

Salvage conformal radiotherapy for biochemical recurrent prostate cancer after radical prostatectomy
by: Carlos R. Monti, et al.
Published: (2006-08-01)

Survival in Patients With Metastatic Prostate Cancer Undergoing Radiotherapy: The Importance of Prostate-Specific Antigen-Based Stratification
by: Zijian Tian, et al.
Published: (2021-06-01)

Challenge and Outcome for the Prostate Squamous Cell Carcinoma Which Developed 8 Years after Low-Dose-Rate Brachytherapy Approached by a Combined Multimodal Treatment with High-Dose-Rate Interstitial Brachytherapy, External Beam Radiation Therapy, and Chemotherapy
by: Toru Matsugasumi, et al.
Published: (2021-06-01)

Radiation dose-response (a Bayesian model) in the radiotherapy of the localized prostatic adenocarcinoma: the reliability of PSA slope changes as a response surrogate endpoint
by: Reza Ali Mohammadpour, et al.
Published: (2019-07-01)

Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy
by: Pinkawa Michael, et al.
Published: (2012-12-01)

DOSE-ESCALATED EXTERNAL BEAM RADIOTHERAPY DURING HORMONO-RADIOTHERAPY FOR PROSTATE CANCER
by: Yu. V. Gumenetskaya, et al.
Published: (2016-07-01)

Editorial: Controversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate Cancer
by: Alan Dal Pra, et al.
Published: (2017-11-01)

Combined Radiation and Hormonal Therapy for Squamous Cell Carcinoma of the Prostate: A Case Report and Review of the Literature
by: Muhammet Fatih Kılınç, et al.
Published: (2016-09-01)

Association of Connexin 32 with Prostate Volume and PSA Level in Prostatic Adenocarcinoma and Adenomyomatous Hyperplasia
by: Havva Erdem, et al.
Published: (2020-06-01)

Prostate-specific antigen is a predictor of the efficacy of salvage radiation therapy in patients with recurrent prostate cancer after radical prostatectomy
by: Р. V. Bulychkin, et al.
Published: (2019-07-01)

Prostate Cancer: what we know and what we would like to know
by: Gianluigi eTaverna, et al.
Published: (2015-05-01)

Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis
by: Narisa Dewi Maulany Darwis, et al.
Published: (2020-08-01)

Long-term prognostic significance of rising PSA levels following radiotherapy for localized prostate cancer – focus on overall survival
by: Carla Freiberger, et al.
Published: (2017-06-01)

Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
by: Sinan Avci, et al.
Published: (2020-04-01)

Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report
by: Rittu Hingorani, et al.
Published: (2014-11-01)

Association between gleason score, psa level, PSAD and prostate volume, in a series of patients with prostate adenocarcinoma
by: Benedetti-Padrón Inés, et al.
Published: (2012-06-01)

Prevalence of prostate adenocarcinoma according to race in an university hospital
by: Milton S Barros, et al.
Published: (2003-08-01)

BEAM THERAPY AND LONG-TERM HORMONAL THERAPY IN PATIENTS WITH PROSTATE CANCER
by: A. O. Karyakin, et al.
Published: (2014-07-01)

BEAM THERAPY AND LONG-TERM HORMONAL THERAPY IN PATIENTS WITH PROSTATE CANCER
by: A. O. Karyakin, et al.
Published: (2014-07-01)

Radical radiotherapy for localized carcinoma of the prostate in elderly patients
by: Radošević-Jelić Ljiljana M., et al.
Published: (2002-01-01)

An external validation of the Candiolo nomogram in a cohort of prostate cancer patients treated by external‐beam radiotherapy
by: Domenico Gabriele, et al.
Published: (2021-05-01)

Outcomes following negative prostate biopsy for patients with persistent disease after radiotherapy for prostate cancer
by: Jacob H. Cohen, et al.
Published: (2010-02-01)

Cutaneous metastases of prostatic adenocarcinoma
by: Shashikant CU Patne, et al.
Published: (2015-01-01)

Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly
by: Hideya Yamazaki, et al.
Published: (2020-11-01)

Association of prostate volume with incidence and aggressiveness of prostate cancer
by: Al-Khalil S, et al.
Published: (2016-10-01)

Is It Effective to Perform Two More Prostate Biopsies According to Prostate-Specific Antigen Level and Prostate Volume in Detecting Prostate Cancer? Prospective Study of 10-Core and 12-Core Prostate Biopsy
by: Byung Il Yoon, et al.
Published: (2012-05-01)

Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review
by: Arslaan Javaeed, et al.
Published: (2020-05-01)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
by: Ahmad Anies Shahab, et al.
Published: (2013-03-01)

The Value of Prostate-Specific Antigen-Related Indexes and Imaging Screening in the Diagnosis of Prostate Cancer
by: Bai X, et al.
Published: (2020-08-01)

Elevated prostate volume index and prostatic chronic inflammation reduce the number of positive cores at first prostate biopsy set: results in 945 consecutive patients
by: Antonio B. Porcaro, et al.

Statistical modeling of bladder motion and deformation in prostate cancer radiotherapy
by: Rios Patiño, Richard
Published: (2017)

Salvage prostate cryoablation for recurrent localized prostate cancer after radiotherapy
by: Justin Ji-Yuen Siu, et al.
Published: (2016-12-01)

Patterns of Care and Treatment Outcomes in Locoregional Squamous Cell Carcinoma of the Prostate
by: Ryan J. Hutten, et al.
Published: (2021-01-01)

Analysis of the Correlationship between Prostate Specific Antigen Related Variables and Risk Factor in Patients with Prostate Carcinoma
by: Daoyuan Wang, et al.
Published: (2015-01-01)

PREDICTION OF COMPLICATIONS DUE TO INTRATISSUE RADIOTHERAPY IN MULTIMODALITY TREATMENT FOR PROSTATE CANCER
by: А. А. Kostin, et al.
Published: (2014-07-01)

PREDICTION OF COMPLICATIONS DUE TO INTRATISSUE RADIOTHERAPY IN MULTIMODALITY TREATMENT FOR PROSTATE CANCER
by: А. А. Kostin, et al.
Published: (2014-07-01)